美国
证券及交易委员会

华盛顿，特区。20549

14A日程安排表

代理声明根据
第14(a)节的
1934年证券法

由报名人提交x

由注册申报人以外的一方提交¨

请勾选适当的框:

¨初步代理声明书

¨  机密，仅供委员会使用（根据规则 14a-6(e)(2) 允许）。

¨最终代理声明书

x决定性的额外资料

¨根据§240.14a-12号寻求材料

第二届春谷收购并购corp

(根据宪章规定的注册人的名称)

(如果非报告人，代理声明的文件人的姓名)

提交申报费（选择适用的方框）：

x无需任何费用

¨  先前已支付的费用与初步材料。

¨按照交易所要求的附表中计算的费用，根据《证券交易所法规》14A(i)(1)和0-11。

美国
证券及交易委员会

华盛顿特区20549

8-K表格

目前的报告
根据1934年证券交易所法案第13或第15(d)节
1934年证券交易所法案

报告日期（最早报告的事件日期）： 2024年10月22日

春谷 收购公司II

(根据其宪章规定的准确名称)

2100 McKinney Ave., 1675号套房

达拉斯，TX 75201。

（总部地址，包括邮政编码）

注册人的电话号码，包括区号：(214) 308-5230

（如自上次报告以来有所变更，则为曾用名称或曾用地址）

根据《证券法》第425条规定的书面通信（17 CFR 230.425)

¨根据证券法规则425条的书面通信(17 CFR 230.425)

¨根据《交易所法》第14a-12条规定，征求材料

¨根据交易所法案第14d-2(b)条规定的     开工前通信情况（17 CFR 240.14d-2(b))。

¨根据证券交易法第12（b）条注册的证券交易所上的交易

根据证券法第12(b)条注册的证券：

请在以下复选框内打勾，表明注册申请人是否为《1933年证券法规则》第405条或本章第230.405条或《1934年证券交易所法》第1202.2条或本章第240.12亿.2条定义的新兴成长型企业。

新兴增长公司x

如果是新兴成长型公司，请通过复选标记表示，如果注册 人选择不使用《证券交易法》第13（a）条规定的任何新的或修订的财务会计准则的延伸过渡期。¨

事项8.01. 其他事项

如先前披露，Spring Valley Acquisition corp. II（以下简称“公司”）已召开股东特别大会，定于2024年10月31日（以下简称“会议”），审议，包括但不限于，修改公司的修正和重述备忘录和章程（以下简称“章程”）的提案，将公司必须完成首次业务组合的日期（以下简称“延期修正提案”）修改至首次公开募股结束后36个月，或公司董事会在其自主决定的情况下，确定对公司最有利的日期之前的日期（以下简称“修正”）。

关于会议，公司发行的每股面值为0.0001美元的A类普通股(IPO中发行的“A类普通股”)的持有人提交股份赎回的截止时间为2024年10月29日美国东部时间下午5:00。

关于会议和修订，公司和Spring Valley Acquisition Sponsor II，LLC（以下简称"赞助方"）打算签署一份或多份形式与《附件10.1》实质上相同的非赎回协议（以下简称"非赎回协议"），与公司的一个或多个非关联股东签署，根据该协议，这些股东同意不在会议中赎回（或撤回并取消任何赎回请求）其A类普通股（以下简称"未赎回股份"）。作为上述不赎回未赎回股份的承诺对价，赞助方预期同意在公司首次业务组合完成交易后（但不迟于两个工作日之后）根据双方议定的比例将赞助方持有的A类普通股转让给这些股东，如果这些股东在会议中不行使其对未赎回股份的赎回权并且延期修正提案被通过和生效。

非赎回协议不预计会增加公司股东对于会议中延期修正提案获批的可能性，但预计会增加会议结束后仍保留在公司trust账户中的所有基金类型的金额，相对于没有非赎回协议情况下trust账户中剩余的金额。

不能保证会提供任何非赎回激励，并且任何非赎回激励的实际条款可能与此处描述的条款存在重大差异。

前述非赎回协议表述，并非完整，仅供参考，特此参照附表 10.1 中的非赎回协议表格，该表格已被完整引用至此。

关于前瞻性声明的谨慎说明

本报告包含前瞻性声明，因此并非历史事实。这包括但不限于关于公司财务状况、业务策略以及管理层未来业务计划和目标的声明。这些声明构成了预测、预测和前瞻性声明，并非对绩效的保证。此外，任何涉及到公司打算在会议中签署一个或多个非赎回协议以及预期任何非赎回协议条款的声明均属于前瞻性声明。这些声明涉及已知和未知的风险、不确定性、假设和其他因素，可能导致公司的实际结果、绩效或成就与这些声明所暗示的任何未来结果、绩效或成就有很大不同。这些声明的特点在于它们并非严格与历史或当前事实相关。在本报告中使用时，诸如“预计”、“相信”、“继续”、“可能”、“估计”、“期望”、“打算”、“可能”、“有可能”、“潜在”、“预测”、“计划”、“潜在”、“具有”、“挖掘”和类似表达可能会识别出前瞻性声明，但是缺少这些词并不意味着该声明非前瞻性。这些前瞻性声明涉及若干风险、不确定性（其中一些超出我们的控制范围）或其他可能导致实际结果或绩效与这些前瞻性声明所暗示的有很大不同的假设。当公司讨论其策略或计划时，公司在进行预测、预测或前瞻性声明。这些声明基于公司管理层的信念和假设以及目前可获得的信息。实际结果和股东价值将受到多种风险和因素的影响，包括但不限于国际、国家和地方经济状况、合并、收购和业务组合风险、融资风险、地缘政治风险、恐怖主义行为或战争以及公司在年度10-k提交给证券交易委员会（“SEC”）的2024年3月29日文件中描述的风险因素以及在2024年10月11日提交的有关会议和修正案的决议委员会签署的最终代理声明，并在公司向SEC提交的其他报告中描述的风险因素。将确定这些结果和股东价值的许多风险因素都超出了公司的能力控制或预测。

所有此类前瞻性声明仅于本报告之日期起效。本公司明确声明不承担任何公开发布更新或修订本处包含的任何前瞻性声明的义务或承诺，以反映公司对相关事项的期望发生任何变化或任何这种声明所基于的事件、条件或情况的变化。我们或代表本公司行事的人所作的所有随后的书面或口头前瞻性声明在其整体上均受本“关于前瞻性声明的警示性说明”部分的限制。

招标人

公司及其董事和高管 以及其他人可能被视为参与者，就延期修正提案及相关事宜向公司股东征求委托。有关公司董事和高管的信息可在公司提交给证监会的2024年3月29日提交的年度报告Form 10-k中获得。有关代理征求参与者的信息以及其直接和间接利益的描述都包含在最终的代理声明中。

附加信息和查找位置

公司敦促投资者、股东和其他感兴趣的人阅读公司向SEC提交的最终代理声明以及其他文件，因为这些文件将包含有关公司和延期修正提议的重要信息。股东可以在SEC的网站免费获取最终代理声明副本。 www.sec.gov 或者直接向公司的代理投资者服务商Sodali＆Co发送请求，地址为333 Ludlow Street, 5th Floor, South Tower, Stamford, Ct 06902，电话号码(203) 658-9400，邮箱：SVII@info.sodali.com。

无要约或征集

本通讯不构成要约 卖出或买入证券的邀约，也不得在 任何可能违反任何司法管辖区 的证券法下，在注册或符合资格之前 买卖证券。 除非通过符合《1933年证券法》 第10条的要求或豁免规定 的招股说明书进行，否则不得进行任何证券发行。

项目9.01.基本报表和展览。

(d) Exhibits.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 10.1

NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST

This Non-Redemption Agreement and Assignment of Economic Interest (this “Agreement”) is entered as of            , 2024 by and among Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (“SVII”), Spring Valley Acquisition Sponsor II, LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned investors (collectively, “Investor”).

RECITALS

WHEREAS, the Sponsor currently holds 7,546,666 Class A ordinary shares, par value $0.0001 per share, (the “Founder Shares”) and one Class B ordinary share, $0.0001 per share (the “Class B ordinary share”), of SVII which were initially purchased in a private placement prior to SVII’s initial public offering (the “IPO”);

WHEREAS, SVII expects to hold an extraordinary general meeting of shareholders (the “Meeting”) for the purpose of approving, among other things, an amendment to SVII’s Amended and Restated Memorandum and Articles of Association, dated 12 October 2022, as amended by that certain amendment dated 11 January 2024 (as it exists on the date hereof, the “Amended and Restated Articles”) to extend the date by which SVII must consummate an initial business combination (the “Initial Business Combination”) to 36 months from the consummation of SVII’s IPO or such earlier date as determined by the board, in its sole discretion (the “Amendment”);

WHEREAS, the Amended and Restated Articles provides that a shareholder of SVII may redeem its Class A ordinary shares initially sold as part of the units in SVII’s IPO (whether they were purchased in SVII’s IPO or thereafter in the open market) (the “Public Shares” and together with the Founder Shares and the Class B ordinary share, the “Ordinary Shares”) in connection with the amendment to the Amended and Restated Articles (as the same are to be amended in connection with the Meeting, the “Articles”) to approve the Amendment, on the terms set forth in the Amended and Restated Articles (“Redemption Rights”);

WHEREAS, subject to the terms and conditions of this Agreement, Investor is willing to forego the exercise of its Redemption Rights in connection with the Amendment, or to validly rescind any previously submitted redemption demand, of certain of the Public Shares held by such Investor upon the terms set forth herein, in connection with which the Sponsor desires to either: (i) surrender to SVII and forfeit for no consideration, that number of Founder Shares set forth on Exhibit A, and SVII desires to issue or cause to be issued to Investor that number of shares set forth opposite such Investor’s name on Exhibit A (the “Promote Shares”) in connection with SVII’s completion of its Initial Business Combination; or (ii) transfer to Investor that number of Founder Shares set forth on Exhibit A (the number of shares to be received by Investor, the “Assigned Securities”).

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Investor, the Sponsor and SVII hereby agree as follows:

Upon the satisfaction of the foregoing conditions, as applicable, the Assigned Securities shall be promptly delivered (and no later than two (2) business days following the closing of the Initial Business Combination) to Investor (or its Permitted Transferees) free and clear of any liens or other encumbrances, other than pursuant to Section 5 of the Letter Agreement, restrictions on transfer imposed by the securities laws, the Joinder (as defined below) and any successor or similar agreement entered into in connection with the Initial Business Combination (which agreement contains no obligations on the part of the Investor other than restrictions on the transfer of the Assigned Securities and which restrictions shall be no less favorable or more restrictive than what is agreed to by the Sponsor and shall be no more restrictive than the restrictions on transfer currently contained in the Letter Agreement). The Sponsor and SVII covenant and agree to facilitate such transfer or Share Issuance to Investor (or its Permitted Transferees) in accordance with the foregoing.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

EXHIBIT A

[Exhibit A to Non-Redemption Agreement]

EXHIBIT B

FORM OF JOINDER

TO

LETTER AGREEMENT

______, 20__

Reference is made to that certain Non-Redemption Agreement and Assignment of Economic Interest, dated as of             , 2024 (the “Agreement”), by and among                  (“Investor”), Spring Valley Acquisition Corp. II (the “Company”) and Spring Valley Acquisition Sponsor II, LLC (the “Sponsor”), pursuant to which Investor acquired securities of the Company from the Sponsor. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Agreement.

By executing this Joinder, Investor hereby agrees, as of the date first set forth above, that Investor shall become a party to that certain Letter Agreement, dated October 12, 2022, as amended by that certain Amendment No. 1 to the Letter Agreement dated January 10, 2024, by and among the Company, the Sponsor and the Company’s officers and directors (as it exists on the date of the Agreement, the “Letter Agreement”), solely with respect to Section 5 of the Letter Agreement, and shall be bound by, and shall be subject to the restrictions set forth thereunder, the terms and provisions of such Section 5 of the Letter Agreement as an Insider (as defined therein) solely with respect to its Assigned Securities or Promote Shares, as applicable; provided, however, that the Investor shall be permitted to transfer its Assigned Securities or Promote Shares, as applicable, to its affiliates.

For the purposes of clarity, it is expressly understood and agreed that each provision contained herein, in the Letter Agreement (to the extent applicable to Investor) is between the Company and Investor, solely, and not between and among Investor and the other shareholders of the Company signatory thereto.

This Joinder may be executed in two or more counterparts, and by facsimile, all of which shall be deemed an original and all of which together shall constitute one instrument.

[Signature Page to Non-Redemption Agreement Joinder]